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Background: The value of Single Photon Emission Computed Tomography stress myocardial perfusion imaging
(SPECT-MPI) for detecting graft disease after coronary artery bypass surgery (CABG) has not been studied
prospectively in an unselected cohort.
Methods: Radial Artery Versus Saphenous Vein Graft Study is a Veterans Affairs Cooperative Study to determine
graft patency rates after CABG surgery. Seventy-nine participants agreed to SPECT-MPI within 24 hours of their
coronary angiogram, one-year after CABG. The choice of the stress protocol was made at the discretion of the
nuclear radiologist and was either a symptom-limited exercise test (n = 68) or an adenosine infusion (n = 11). The
SPECT-MPI results were interpreted independent of the angiographic results and estimates of sensitivity, specificity
and accuracy were based on the prediction of a graft stenosis of ≥70% on coronary angiogram.
Results: A significant stenosis was present in 38 (48%) of 79 patients and 56 (22%) of 251 grafts. In those stress
tests with an optimal exercise heart rate response (>80% maximum predicted heart rate) (n = 26) sensitivity,
specificity and accuracy of SPECT-MPI for predicting the graft stenosis was 77%, 69% and 73% respectively. With
adenosine (n = 11) it was 75%, 57% and 64%, respectively. Among participants with a suboptimal exercise heart rate
response, the sensitivity of SPECT-MPI for predicting a graft stenosis was <50%. The accuracy of SPECT-MPI for
detecting graft disease did not vary significantly with ischemic territory.
Conclusions: Under optimal stress conditions, SPECT-MPI has a good sensitivity and accuracy for detecting graft
disease in an unselected patient population 1 year post-CABG.
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Coronary artery bypass graft (CABG) surgery reduces angina
and prolongs life in patients with severe coronary heart dis-
ease, however, the long-term effectiveness of this procedure
is limited by thrombosis and accelerated atherosclerosis of
the bypass grafts. It has been reported that approximately
15% of saphenous venous grafts occlude in the first year after
CABG surgery and that the majority of these occlusions are
clinically silent [1]. By the 6th and 10th year after CABG, vein
graft patency rates fall to approximately 75% and 60%, re-
spectively, [1,2] accompanied by recurrence of angina and
clinical events [3]. However, symptom status is not a reliable* Correspondence: baselaloul@hotmail.com
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reproduction in any medium, provided the orindicator of significant graft disease with a reported sensitiv-
ity and specificity of 60% and 20%, respectively [4]. Thus, a
non-invasive test to detect asymptomatic coronary artery by-
pass graft disease could be clinically useful.
Single photon emission computed tomography myocar-
dial perfusion imaging (SPECT-MPI) has been shown to be
an accurate test for detecting threatened bypass graft dis-
ease in patients presenting with unstable symptoms [5,6]
and provides important prognostic information after CABG
surgery [5-9]. However, despite its widespread acceptance
in clinical practice, whether the celebratory results of
SPECT-MPI in unstable patients can be extrapolated to all
patients with prior CABG regardless of their symptom sta-
tus is unclear.
Accordingly, the aim of this study was to assess the
sensitivity, specificity and accuracy of stress SPECT-MPIl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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lected group of patients who underwent routine coron-
ary angiogram one year after CABG per the protocol of
the Veterans Affairs’ (VA) Cooperative trial on patency
of radial artery and saphenous vein grafts [10].
Methods
The Human Studies Subcommittee of the Research and
Development committee at the Minneapolis VA Medical
Center and the Executive Committee of the VA Co-
operative Study (CSP #474) approved this study. All
patients gave informed consent. The design was a pro-
spective analysis of a cohort enrolled from the Minneap-
olis VA Medical Center who participated in the
multicenter VA Cooperative trial on radial artery versus
saphenous vein graft patency rates trial (NCT0005847)
[10]. All subjects within the sub-study agreed to undergo
either exercise or pharmacologic stress SPECT-MPI
within 24 hours of their follow-up coronary angiography,
which was scheduled at one year following CABG.
Nuclear stress test
Among those patients who were deemed suitable for a
treadmill exercise test by the Nuclear Radiologist, a
standard Bruce protocol was performed. Patients were
allowed to exercise until an end-point was reached
(moderate to severe angina, shortness of breath, fa-
tigue or leg weakness, ≥2 mm ST-segment depression,
hypotension, or severe arrhythmias). Technetium-99 m
tetrofosmin (Myoview) was injected at near-peak exercise,
and the patients were asked to continue exercise for an
additional minute. Electrocardiogram (ECG) tracings were
recorded at 30-second intervals and continued into recov-
ery, until the heart rate returned to baseline. Heart rate and
blood pressure measurements were performed at rest, with
each change in stage, and at peak exercise. In those patients
who were not deemed candidates for exercise based
on review of their clinical history, a pharmacologic
stress test was performed with adenosine. In advance,
they were asked to avoid consumption of any pro-
ducts containing methylxanthines, including coffee,
tea or other caffeinated beverages, caffeine-containing
drug products, and theophylline for at least 12 hours
prior to the testing. A 12-lead ECG tracing and a
blood pressure measure were recorded every minute
during the infusion until 5 minutes following recov-
ery. The Adenosine infusion was given at a rate of
140 mcg/kg/min over 3 minutes.
All images were acquired and processed according to
the American Society of Nuclear Cardiology guidelines
using one-day rest/stress protocol. The radiotracer
technetium-99 m tetrofosmin (Myoview) was adminis-
tered based on body weight. For the rest portion of the
study, a low dose (one-fourth of the total dose, or8–12 mCi) was given and for the stress portion, a larger
dose (three-fourths of the total dose, or 24–36 mCi) was
administered. Among the patients who underwent an ex-
ercise stress test protocol, the rest dose of technetium-
99 m tetrofosmin was given intravenously followed by a
30 minute waiting period, after which the first set of
images was acquired over 15 minutes. After a short delay,
the exercise stress test was performed and the dose of
technetium-99 m tetrofosmin was given 1 minute before
the completion of exercise. After a 45-minute waiting
period, a second set of images was acquired and collected
over 20 minutes. Among the patients who underwent the
Adenosine stress protocol, the rest dose of technetium-
99 m tetrofosmin was given intravenously followed by a
30 minutes waiting period after which the first set of im-
aging was performed. After a short delay, the six-minute
Adenosine infusion was begun and at 3 minutes, the stress
dose of technetium-99 m tetrofosmin was injected. After a
45-minute delay, a second set of images was acquired.
All raw data of gated SPECT images were recon-
structed using standard back-projection and identical fil-
tering. Quantitative SPECT was performed using a
previously validated automated program that determines
the extent and severity of left ventricle perfusion defect
size and the extent of reversible (ischemia) or fixed
(scar) perfusion defects [11]. In addition, the automated
program was used to derive the summed stress score
(SSS), summed rest score (SRS), and summed difference
score (SDS) based on conventional 17-segment model.
The program assigned a score of 0 to 4 to each segment
based on activity level: 0 = normal and 4 = absent. In
addition to perfusion data, the left ventricular ejection
fraction, end-diastolic volume, and end-systolic volume
were measured from the gated SPECT as previously
described [11]. The SPECT images were interpreted by 2
experienced readers according to a standard segment
scoring system that provides semi-quantitative informa-
tion regarding total number of defects and the degree of
ischemia versus infarction. The agreement between the 2
readers was 82% with a Kappa value of 0.62 [12]. The in-
terpretation of the SPECT was made without knowledge
of the results of the coronary angiogram.
Coronary angiography
Coronary angiography was performed one-year post
CABG and within 24 hours of the SPECT-MPI. All cine-
angiograms were performed using standard techniques,
including nitroglycerin administration, in at least 2 or-
thogonal angiographic views (45°left anterior oblique and
45° right anterior oblique). All angiograms were inter-
preted at the core laboratory, blinded to the results of the
SPECT-MPI, using quantitative coronary angiography per
the VA Cooperative study protocol [10]. A cutoff of sten-
osis severity ≥70% was used to define graft disease.
Table 1 Baseline characteristics of study participants
Age (years) ± SD 60± 7
Male Gender (%) 78 (99)
BMI (kg/m2) ± SD 30± 6
Arterial hypertension (%) 69 (87)
Chronic obstructive pulmonary disease (%) 19 (24)
Cerebrovascular disease (%) 9 (11)
Diabetes mellitus (%) 23 (29)
Current smoking (%) 22 (28)
Surgery – CABG
Priority
Elective (%) 74 (94)
Urgent (%) 5 (6)
Grafts
LIMA (%) 77 (97)
Radial Artery 37 (47)
≥ 1 Saphenous Vein Graft (No Radial Artery Graft) 42 (53)
Total Number of Grafts
Two (%) 15 (19)
Three (%) 36 (46)
Four (%) 28 (35)
BMI: Body mass index. CABG: Coronary artery bypass Grafting.
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Continuous variables were displayed as mean ± one
standard deviation and categorical variables as percen-
tages. Prevalence of chronic obstructive pulmonary dis-
ease (COPD) in patients with versus without adequate
heart rate response to exercise was compared with chi-
square test. Statistical analyses were performed using
SPSS version 16. A two-tailed p value of < 0.05 was con-
sidered statistically significant. Invasive bypass angiog-
raphy served as the “gold standard” to define the
presence of graft disease. The sensitivity, specificity,
positive predictive value, negative predictive value and
accuracy of SPECT'-MPI to detect significant graft dis-
ease on coronary angiography were calculated as follows
[13]. Sensitivity is defined as the number of true posi-
tives divided by the combined number of true positives
and false negatives. Specificity is the number of true
negatives divided by the combined number of true nega-
tives and false positives. Positive predictive value is the
number of true positives divided by the combined num-
ber of true positives and false positives. Negative predict-
ive value is the number of true negatives divided by the
combined number of true negatives and false negatives.
Cohen’s kappa coefficient (κ) is a statistical measure of
inter-rater agreement. It is calculated as the relative
observed agreement among readers minus the hypothet-
ical probability of chance agreement divided by 1 minus
the hypothetical probability of chance agreement. If the
raters are in complete agreement then κ= 1. If there is
no agreement among the raters other than what would
be expected by chance, then κ= 0 [12].
Results
From February 2003 through February 2008, 82 patients
were enrolled in the VA Cooperative sub-study and 79
patients were included in the final analysis. Three
patients were excluded because one declined coronary
angiography, one had exercise stress test in the presence
of left bundle branch block and one had Thallium tracer
instead of Technetium tracer during SPECT-MPI. The
majority of study participants were male with an average
age of 60 ± 7 years (Table 1).
Coronary angiography
At the scheduled coronary angiogram at 1-year post-
CABG, 38 of the 79 (48%) patients had significant graft
disease (≥70% stenosis, including total occlusion) involv-
ing 56 of 251 (22%) potential grafts. There was 77 left
internal mamary grafts and of those 6 had significant
disease (7.8%). A total of 37 radial artery grafts were
used and of those 12 had significant disease (32%).
Lastly, 137 saphenous vein grafts were used and of those
38 grafts had significant disease (28%). A complete graft
occlusion was present in 33 (13%) of 251 grafts.Nuclear stress test
Exercise SPECT-MPI was the designated stress protocol
in 68 (86%) of the 79 study patients. As a group, the
heart rate at peak exercise was 122 ± 18 beats per minute
and the total exercise time was 8 ± 3 minutes. The peak
double product was 19,912 ± 4,310 and the mean max-
imum predicted heart rate (MPHR%) was 80% ± 20%.
Among those patients who underwent symptom-limited
exercise, the test was adequate (i.e. MPHR > 80%) in 26
patients (38%) and inadequate (i.e. MPHR ≤ 80%) in 42
patients (62%). Pharmacological SPECT-MPI was the
designated stress protocol in 11 (14%) of the 79 patients.
Among patients with a suboptimal exercise perform-
ance, a higher prevalence of chronic obstructive pul-
monary disease was noted compared with individuals
with an adequate exercise performance (82% versus
18%; p < 0.05).Detection of graft disease with SPECT
An abnormal SPECT-MPI was present in 42 (53%) of the
79 patients, including 14 patients with an adequate exer-
cise heart rate response, 21 patients with an inadequate
exercise heart rate response and 7 patients with a pharma-
cological stress protocol (Table 2). An adequate exercise
stress SPECT-MPI protocol, with an ability to achieve
Table 2 Results of nuclear stress test
Nuclear Stress Test
Exercise (Tc-99 m) -number of patients (%) 68 (86)
Adenosine (Tc-99 m) –number of patients (%) 11 (14)
Peak Heart Rate (bpm) ± SD 122± 18
Exercise Time (minutes) ± SD 8± 3
Peak Double Product ± SD 19,912± 4310
SRS ± SD 5± 8
SSS ± SD 6± 8
SDS± SD 1± 2
Type of Perfusion Defect
No Defects (%) 37 (47)
Reversible (%) 7 (9)
Fixed (%) 23 (29)
Mixed (%) 12 (15)
Ejection Fraction ± SD 53± 12
End Systolic Volume (cc3) ± SD 59± 41
End Diastolic Volume (cc3) ± SD 115± 53
Total Dose (mCi) ± SD 47± 7
Bpm: beats per minute. TC: Technetium. SRS: Sum rest score. SSS: Sum stress
score. SRS: Sum rest score. SDS: Sum difference score. mCi: Millicurie.













Sensitivity of Detecting Graft Disease
Accuracy of Detecting Graft Disease
Figure 1 The sensitivity of detecting graft disease at 1-year
following CABG is shown according to the stress protocol and
achievement of adequate heart rate response.
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69%, positive predictive value of 71% and negative predict-
ive value of 75% for the detection of graft disease (Table 3).
On the other hand, an inadequate exercise stress SPECT-
MPI protocol, with an inability to achieve >80% of the
MPHR had a sensitivity for detecting a graft stenosis of
43%, with a specificity of 52%, positive predictive value of
47% and negative predictive value of 48%. Conversely,
pharmacological stress SPECT-MPI had a sensitivity for
detecting graft disease of 75%, with a specificity of 57%,
positive predictive value of 50% and negative predictive
value of 80% (Figure 1).
The accuracy of SPECT-MPI varied slightly by the
myocardial territory supplied by the bypass graft
(Table 4). An adequate exercise stress SPECT-MPI
protocol had an accuracy of 81%, 76% and 78% for grafts
supplying the anterior, lateral and inferior walls, respect-
ively. On the other hand, adenosine stress protocol had
an accuracy of 55%, 80% and 63% for grafts supplying
the anterior, lateral and inferior walls, respectively.Table 3 Performance of single photon emission computed to
stress testing for detecting coronary artery bypass graft pate
Stress test Stress test adequacy
Exercise SPECT-MPI (n = 68) Adequate: MPHR>80% (n= 26)
Inadequate: MPHR≤ 80% (n= 42)
Pharmacologic SPECT-MPI (n = 11)
MPHR: Maximum predicted heart rate. PPV: Positive predictive value. NPV: NegativeDiscussion
In this prospective cohort study of unselected patients
returning for a coronary angiogram at one-year follow-
ing CABG, SPECT-MPI was shown to have a good sen-
sitivity, specificity, and accuracy for detecting bypass
graft disease with an adequate exercise or pharmaco-
logical stress test. However, in those individuals who
failed to achieve >80% of their maximal predictive heart
rate, the sensitivity, specificity and accuracy decreased
significantly. We also found that the accuracy of SPECT-
MPI did not vary between different myocardial territor-
ies. To our knowledge, these are the first prospective
data on the accuracy of SPECT-MPI in an unselected
cohort of patients after CABG.
There are limited data on the accuracy of SPECT im-
aging in asymptomatic patients with prior CABG. How-
ever, in previous retrospective studies of symptomatic
patients who underwent coronary angiography, the sensi-
tivity and specificity of detecting graft disease as judged by
exercise thallium-201 SPECT was 80% and 87% respect-
ively [5]. Further, sensitivity of SPECT-MPI was signifi-
cantly higher than that of the exercise electrocardiogram
stress test in patients with typical recurrent angina (84%
vs. 24%), as well as in those with atypical symptoms (70%
vs. 50%). Moreover, among symptomatic patients who
underwent coronary angiography, comparable results were
shown with adenosine thallium-201 SPECT, with a sensi-
tivity and specificity for detecting graft disease of 96% and
60%, respectively [14]. A low specificity was attributed tomography myocardial perfusion imaging (SPECT-MPI)
ncy
Sensitivity (%) Specificity (%) PPV (%) NPV (%)
77 69 71 75
43 52 47 48
75 57 50 80
predictive value.
Table 4 Accuracy of single photon emission computed tomography myocardial perfusion imaging (SPECT-MPI) stress
testing for detecting coronary artery bypass graft disease according to the territory that is supplied by the diseased
graft





73 81 76 78
Inadequate: MPHR≤ 80%
(n= 42)
48 83 55 54
Pharmacologic SPECT-MPI (n = 11) 64 55 80 63
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distribution of non-bypassed native vessels, and partial
volume effects as a result of regional wall motion and con-
duction abnormalities [14]. Because the pretest probability
of bypass graft disease in these symptomatic patients was
elevated, the accuracy of the SPECT-MPI found in these
studies may not necessarily be extrapolated to unselected
patient cohorts. Thus the present investigation fills this
gap in the literature by assessing the utility of SPECT-MPI
in an unselected study cohort decreasing the chances of a
selection bias.
We have found that with optimal stress conditions,
SPECT-MPI has a sensitivity and a negative predictive
value of >75% with either adequate exercise or pharma-
cological stress testing. The sensitivity is slightly lower
than prior studies because of differences in symptoms at
the time of presentation. At 5 years following bypass
surgery, it is expected that 25% of vein grafts have sig-
nificant disease and a substantial proportion of patients
have symptoms, increasing the pretest probability. Fur-
ther, exclusion of patients with a negative stress test in
previous studies might have introduced a selection bias
in the sensitivity and specificity calculations [15]. Indeed,
exclusion of selected patients may curtail the number of
true-negative results and consequently raises the sensi-
tivity of a test [16].
In the present study, SPECT-MPI was more sensitive
and specific for detecting bypass graft disease in patients
with an adequate exercise heart rate response compared
with those who did not achieve an adequate heart rate.
The sensitivity of adequate exercise SPECT-MPI was
77%, in comparison to < 50% in patients with an inad-
equate exercise heart rate response. These data under-
score the importance of continuing exercise stress
testing until MPHR is achieved or opting for adenosine
protocol in patients who are unlikely to achieve ad-
equate exercise.
Until now invasive bypass graft angiography remains
the gold standard for detecting graft disease [17,18]. As
shown in this study SPECT-MPI is useful to detect graft
disease accurately. Recently, it has been shown that
combining perfusion CT imaging and cardiac CT angi-
ography is feasible, and CT perfusion adds incremental
value to cardiac CT angiography in the detection ofsignificant coronary artery disease [19,20], but these
studies were not performed specifically in patients with
bypass grafts.
In our study 38 of the 79 (48%) patients had significant
graft disease (≥70% stenosis, including total occlusion)
involving 56 of 251 (22%) potential grafts, which is
slightly higher than previously reported. It is known that
approximately 15% of saphenous venous grafts occlude
in the first year after CABG surgery and that the major-
ity of these occlusions are clinically silent [1]. Potential
explanations for these differences are considered. First,
prior studies have reported more significant stenosis or
complete occlusion to define graft disease, whereas we
reported any stenosis > 70%. Of note a complete graft oc-
clusion was present in 33 (13%) of 251 grafts, which is
similar to previous reports. Second in a study with a
small sample size like ours, a few patients can alter the
proportion with significant lesions. Third, the fact that
99% of patients were male and 28% of them were active
smokers might have contributed to the slight increase in
graft disease.
The most notable strength of this investigation is its
prospective study design. Indeed, all of the previous in-
formation in this area has originated from retrospective
analyses in which potential bias has been created in re-
ferral to either the nuclear stress lab and/or coronary
angiography. In addition to the prospective nature and
the all inclusiveness of the participants, an additional
strength of the present study is that the cardiac
catheterization and the nuclear imaging tests were per-
formed within 24 hours of each other and both tests
were interpreted without knowledge of the results of the
other. In previous studies, these examinations were
interpreted weeks and sometimes months apart, during
which changes in coronary anatomy or perfusion might
have occurred. This study also has some limitations.
First, 42 out of 68 patients who performed an exercise
stress SPECT did not achieve the MPHR. Chronic beta-
blocker use and high prevalence of non-cardiac co-mor-
bidities such as COPD are the most likely explanation
for this finding. This observation raises the issue of
whether a pharmacological stress should be considered
the preferred modality in this patient population. Sec-
ond, it might be difficult to assess the perfusion defects
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circulation status and collateral vessels. It is possible that
some perfusion defects were due to preexisting distal
vessel disease. Third, the sample size is small in statis-
tical terms. Fourth, nearly all patients were male with
high prevalence of COPD. Caution should be exercised
in extrapolating these results to women and the study
findings require confirmation in other populations with
a lower prevalence of COPD.
Conclusions
In this prospective cohort study of an unselected cohort of
patients at one year following CABG, SPECT-MPI showed
a good sensitivity, specificity, and accuracy for detecting
angiographic bypass graft disease under optimal stress
conditions.
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